Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patients

Objectives: Chemotherapy-induced peripheral neuropathy (CIPN), a frequently occurring adverse event associated with paclitaxel/carboplatin (TC) combination therapy, causes limb pain and markedly reduces the patient’s quality of life. Since zinc has been reported to be associated with neuropathic p...

Full description

Saved in:
Bibliographic Details
Main Authors: Yutaka Torii, Kana Naito, Junichi Takagi, Akira Yasue, Kazuhiko Tsukada, Takuma Fujii, Haruki Nishizawa
Format: Article
Language:English
Published: Fujita Medical Society 2025-02-01
Series:Fujita Medical Journal
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/fmj/11/1/11_2024-013/_pdf/-char/ja
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542406280478720
author Yutaka Torii
Kana Naito
Junichi Takagi
Akira Yasue
Kazuhiko Tsukada
Takuma Fujii
Haruki Nishizawa
author_facet Yutaka Torii
Kana Naito
Junichi Takagi
Akira Yasue
Kazuhiko Tsukada
Takuma Fujii
Haruki Nishizawa
author_sort Yutaka Torii
collection DOAJ
description Objectives: Chemotherapy-induced peripheral neuropathy (CIPN), a frequently occurring adverse event associated with paclitaxel/carboplatin (TC) combination therapy, causes limb pain and markedly reduces the patient’s quality of life. Since zinc has been reported to be associated with neuropathic pain, we investigated the relationship between CIPN due to TC therapy and serum zinc levels. Methods: The study included 13 patients with gynecological cancer whose serum zinc levels were measured before and during TC therapy. CIPN was classified into severity grades based on the Common Terminology Criteria for Adverse Events v5.0. A retrospective analysis was conducted on the relationship between the serum zinc level before TC therapy (PreZn), the minimum serum zinc level measured during TC therapy (MinZn), the MinZn/PreZn ratio, the number of TC treatment cycles, and the maximum grade of CIPN (MaxG) using Pearson’s correlation coefficient. Moreover, an analysis was also conducted on clinical factors influencing MaxG, as well as fluctuations in serum zinc levels and CIPN grades for each cycle of TC therapy. Results: A negative correlation was observed between the MinZn/PreZn ratio and MaxG (r=–0.557, p=0.048). The clinical factors influencing CIPN remained unclear, and the decrease in serum zinc levels and the aggravation of CIPN plateaued after the third cycle. Conclusions: If a decrease in serum zinc levels during TC therapy is smaller than before therapy, it may imply the existence of a causal relationship that suppresses the aggravation of CIPN.
format Article
id doaj-art-d12d837415ed4623b2ee8df75164c056
institution Kabale University
issn 2189-7247
2189-7255
language English
publishDate 2025-02-01
publisher Fujita Medical Society
record_format Article
series Fujita Medical Journal
spelling doaj-art-d12d837415ed4623b2ee8df75164c0562025-02-04T05:25:23ZengFujita Medical SocietyFujita Medical Journal2189-72472189-72552025-02-01111111910.20407/fmj.2024-013Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patientsYutaka Torii0Kana Naito1Junichi Takagi2Akira Yasue3Kazuhiko Tsukada4Takuma Fujii5Haruki Nishizawa6Department of Obstetrics and Gynecology, Fujita Health University, School of Medicine; Department of Gynecology, Fujita Health University Okazaki Medical CenterDepartment of Obstetrics and Gynecology, Fujita Health University, School of MedicineDepartment of Obstetrics and Gynecology, Fujita Health University, School of Medicine; Department of Gynecology, Fujita Health University Okazaki Medical CenterDepartment of Gynecology, Fujita Health University Okazaki Medical CenterDepartment of Gynecology, Fujita Health University Okazaki Medical CenterDepartment of Gynecology, Fujita Health University Okazaki Medical CenterDepartment of Obstetrics and Gynecology, Fujita Health University, School of MedicineObjectives: Chemotherapy-induced peripheral neuropathy (CIPN), a frequently occurring adverse event associated with paclitaxel/carboplatin (TC) combination therapy, causes limb pain and markedly reduces the patient’s quality of life. Since zinc has been reported to be associated with neuropathic pain, we investigated the relationship between CIPN due to TC therapy and serum zinc levels. Methods: The study included 13 patients with gynecological cancer whose serum zinc levels were measured before and during TC therapy. CIPN was classified into severity grades based on the Common Terminology Criteria for Adverse Events v5.0. A retrospective analysis was conducted on the relationship between the serum zinc level before TC therapy (PreZn), the minimum serum zinc level measured during TC therapy (MinZn), the MinZn/PreZn ratio, the number of TC treatment cycles, and the maximum grade of CIPN (MaxG) using Pearson’s correlation coefficient. Moreover, an analysis was also conducted on clinical factors influencing MaxG, as well as fluctuations in serum zinc levels and CIPN grades for each cycle of TC therapy. Results: A negative correlation was observed between the MinZn/PreZn ratio and MaxG (r=–0.557, p=0.048). The clinical factors influencing CIPN remained unclear, and the decrease in serum zinc levels and the aggravation of CIPN plateaued after the third cycle. Conclusions: If a decrease in serum zinc levels during TC therapy is smaller than before therapy, it may imply the existence of a causal relationship that suppresses the aggravation of CIPN.https://www.jstage.jst.go.jp/article/fmj/11/1/11_2024-013/_pdf/-char/jachemotherapy-induced peripheral neuropathyzinctc therapy
spellingShingle Yutaka Torii
Kana Naito
Junichi Takagi
Akira Yasue
Kazuhiko Tsukada
Takuma Fujii
Haruki Nishizawa
Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patients
Fujita Medical Journal
chemotherapy-induced peripheral neuropathy
zinc
tc therapy
title Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patients
title_full Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patients
title_fullStr Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patients
title_full_unstemmed Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patients
title_short Examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel/carboplatin combination therapy in gynecological cancer patients
title_sort examination of the relationship between serum zinc levels and peripheral neuropathy induced by paclitaxel carboplatin combination therapy in gynecological cancer patients
topic chemotherapy-induced peripheral neuropathy
zinc
tc therapy
url https://www.jstage.jst.go.jp/article/fmj/11/1/11_2024-013/_pdf/-char/ja
work_keys_str_mv AT yutakatorii examinationoftherelationshipbetweenserumzinclevelsandperipheralneuropathyinducedbypaclitaxelcarboplatincombinationtherapyingynecologicalcancerpatients
AT kananaito examinationoftherelationshipbetweenserumzinclevelsandperipheralneuropathyinducedbypaclitaxelcarboplatincombinationtherapyingynecologicalcancerpatients
AT junichitakagi examinationoftherelationshipbetweenserumzinclevelsandperipheralneuropathyinducedbypaclitaxelcarboplatincombinationtherapyingynecologicalcancerpatients
AT akirayasue examinationoftherelationshipbetweenserumzinclevelsandperipheralneuropathyinducedbypaclitaxelcarboplatincombinationtherapyingynecologicalcancerpatients
AT kazuhikotsukada examinationoftherelationshipbetweenserumzinclevelsandperipheralneuropathyinducedbypaclitaxelcarboplatincombinationtherapyingynecologicalcancerpatients
AT takumafujii examinationoftherelationshipbetweenserumzinclevelsandperipheralneuropathyinducedbypaclitaxelcarboplatincombinationtherapyingynecologicalcancerpatients
AT harukinishizawa examinationoftherelationshipbetweenserumzinclevelsandperipheralneuropathyinducedbypaclitaxelcarboplatincombinationtherapyingynecologicalcancerpatients